Related Experiment Video

Updated: May 5, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

56.5K

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis

W Z Mehal1, Y M Lo, B P Wordsworth

  • 1Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital, Oxford, England.

Gastroenterology
|January 1, 1994
PubMed

Insights

Primary sclerosing cholangitis (PSC) is linked to specific human leukocyte antigen (HLA) alleles. HLA-DR52a and HLA-Dw2 are the primary genetic associations, while HLA-DR4 indicates faster disease progression in PSC patients.

Area of Science:

  • Immunogenetics
  • Gastroenterology
  • Autoimmune Diseases

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic biliary inflammation.
  • Known associations include increased human leukocyte antigen (HLA) alleles DR3, DR52a, DR2, Dw2, and decreased DR4.
  • The primary contributing HLA alleles remain uncertain.

Purpose of the Study:

  • Identify primary HLA associations in PSC.
  • Determine if HLA alleles predict disease progression.

Main Methods:

  • Genotyping of 83 PSC patients and 131 controls using molecular techniques.
  • Analysis focused on HLA alleles DR2, DR3, DR4, DRw12, DR52a, and Dw2.
  • Archival tissue samples were utilized.

Main Results:

  • Significant increases in HLA DR3, DR52a, DR2, and Dw2 in PSC patients.
  • Higher relative risk for HLA-DR52a and HLA-Dw2 compared to HLA-DR3 and HLA-DR2.
  • HLA-DR4 decrease was observed, potentially due to DR3/DR2 increase.
  • HLA-DR4, not HLA-DR52a, correlated with rapid disease progression.

Conclusions:

  • HLA-DR52a and HLA-Dw2 are the strongest candidates for the primary HLA association with PSC.
  • HLA-DR4 is a significant marker for rapid disease progression in PSC.
  • Findings aid in understanding PSC pathogenesis and patient stratification.
Abstract

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

9.8K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.4K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42